These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 38669388)

  • 21. Gut microbiota-derived short-chain fatty acids and kidney diseases.
    Li L; Ma L; Fu P
    Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response.
    Huang W; Zhou L; Guo H; Xu Y; Xu Y
    Metabolism; 2017 Mar; 68():20-30. PubMed ID: 28183450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-Chain Fatty Acids in the Microbiota-Gut-Brain Axis: Role in Neurodegenerative Disorders and Viral Infections.
    Majumdar A; Siva Venkatesh IP; Basu A
    ACS Chem Neurosci; 2023 Mar; 14(6):1045-1062. PubMed ID: 36868874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut-Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson's Disease.
    Riegelman E; Xue KS; Wang JS; Tang L
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential Therapeutic Effects of Short-Chain Fatty Acids on Chronic Pain.
    Tang Y; Du J; Wu H; Wang M; Liu S; Tao F
    Curr Neuropharmacol; 2024; 22(2):191-203. PubMed ID: 36173071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS).
    Ratajczak W; Mizerski A; Rył A; Słojewski M; Sipak O; Piasecka M; Laszczyńska M
    Aging (Albany NY); 2021 Apr; 13(8):10934-10954. PubMed ID: 33847600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?
    Barrea L; Muscogiuri G; Annunziata G; Laudisio D; Pugliese G; Salzano C; Colao A; Savastano S
    Hormones (Athens); 2019 Sep; 18(3):245-250. PubMed ID: 30840230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients.
    Wu G; Jiang Z; Pu Y; Chen S; Wang T; Wang Y; Xu X; Wang S; Jin M; Yao Y; Liu Y; Ke S; Liu S
    BMC Neurol; 2022 Jan; 22(1):13. PubMed ID: 34996385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-chain fatty acid - A critical interfering factor for allergic diseases.
    Liu Y; Liu J; Du M; Yang H; Shi R; Shi Y; Zhang S; Zhao Y; Lan J
    Chem Biol Interact; 2023 Nov; 385():110739. PubMed ID: 37805176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
    Duan H; Wang L; Huangfu M; Li H
    Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
    Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
    Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication.
    Silva YP; Bernardi A; Frozza RL
    Front Endocrinol (Lausanne); 2020; 11():25. PubMed ID: 32082260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?
    Ohira H; Tsutsui W; Fujioka Y
    J Atheroscler Thromb; 2017 Jul; 24(7):660-672. PubMed ID: 28552897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of short-chain fatty acids in central nervous system diseases.
    Dong Y; Cui C
    Mol Cell Biochem; 2022 Nov; 477(11):2595-2607. PubMed ID: 35596843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
    Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
    Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
    Sivaprakasam S; Prasad PD; Singh N
    Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiota fermentation characteristics of acylated starches and the regulation mechanism of short-chain fatty acids on hepatic steatosis.
    Li M; Wang J; Wang F; Strappe P; Liu W; Zheng J; Zhou Z; Zhang Y
    Food Funct; 2021 Sep; 12(18):8659-8668. PubMed ID: 34346457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of short-chain fatty acids in microbiota-gut-brain communication.
    Dalile B; Van Oudenhove L; Vervliet B; Verbeke K
    Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):461-478. PubMed ID: 31123355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Environmental neurotoxicants and inflammasome activation in Parkinson's disease - A focus on the gut-brain axis.
    Johnson AM; Ou ZA; Gordon R; Saminathan H
    Int J Biochem Cell Biol; 2022 Jan; 142():106113. PubMed ID: 34737076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
    Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
    Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.